A rare case of involuting fibroadenoma in a young premenopausal female

Case report OA: gold CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-13 ⓘ

This case report documents the progression of a biopsy-proven fibroadenoma in a young premenopausal female, challenging the typical association of tumor involution with postmenopausal estrogen decline.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-11 · read from full text ⓘ

This case report describes a 28-year-old premenopausal woman with a palpable breast mass that demonstrated interval growth and morphological changes from benign to suspicious features over six years. Imaging revealed the development of angular margins and coarse calcifications, prompting a biopsy that confirmed the diagnosis of an involuting fibroadenoma despite the absence of typical hormonal triggers for involution. The paper highlights the diagnostic challenge posed by atypical radiologic presentations in younger patients and emphasizes the importance of multidisciplinary evaluation to distinguish these lesions from malignancy. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Fibroadenomas are prevalent among women in their teens and twenties, and while they generally present as palpable masses, their involution can present unique diagnostic and management challenges. The involution process is marked by a transition from a well-defined, hypercellular tumor to a more fibrotic and less cellular state, often leading to decreased size or complete resolution of the mass over time. This process of involution is typically seen with decreased estrogen which occurs after menopause. This case report presents a unique opportunity of following the progression of a biopsy proven fibroadenoma in a young premenopausal female without any medical or surgical history.
Full text 9,413 characters · extracted from pmc-nxml · 6 sections · click to expand

Case

28-year-old female presented with a palpable abnormality in the left breast. Ultrasound was performed for further evaluation. A 1.8×1.8×0.7 cm hypoechoic mass with angular margins was found at the area of palpable concern at 12 o'clock, 1 centimeter from the nipple. Internal foci of echogenicity were seen, which are consistent with calcifications ( Fig. 1 ). After obtaining additional history, the patient reported having felt this lump since she was 18 years old. Prior imaging of the same region from 6 years ago showed a hypoechoic oval mass with circumscribed margins, which are all benign features ( Fig. 2 ). This had shown stability over 2 years prior, at which point it was given a BI-RADS assessment category 2 (benign). Due to the change from benign circumscribed margins to suspicious angular margins, and interval development of calcifications within this mass, as well as interval growth, bilateral mammograms were subsequently performed. At the area of palpable concern, mammography demonstrated an oval mass associated with coarse heterogeneous calcifications ( Fig. 3 ). No abnormalities were seen in the contralateral breast. This was given a BI-RADS assessment category 4 (suspicious) and an ultrasound guided biopsy was subsequently performed. The pathology report revealed minute fragments of fibroadenomatous nodule. This was deemed concordant with the radiologic findings. Fig. 1 Left breast ultrasound static image: 12:00 1 cm from the nipple at the area of palpable concern demonstrates a hypoechoic parallel mass with angular margins. Internal foci of echogenicity with shadowing consistent with calcification. This mass measures 1.8 × 1.8 × 0.7 cm. Fig 1 – Fig. 2 Left breast ultrasound static image for 6 years prior: 12:00 1 cm from the nipple at the area of palpable concern demonstrates a hypoechoic oval circumscribed parallel mass without posterior features. This mass measures 1.8 × 1.6 × 0.6 cm. Fig 2 – Fig. 3 DBT of the left breast: 12:00 1 cm from the nipple at the palpable area of concern demonstrates a high density oval mass with associated coarse heterogeneous calcifications. Fig 3 – Left breast ultrasound static image: 12:00 1 cm from the nipple at the area of palpable concern demonstrates a hypoechoic parallel mass with angular margins. Internal foci of echogenicity with shadowing consistent with calcification. This mass measures 1.8 × 1.8 × 0.7 cm. Left breast ultrasound static image for 6 years prior: 12:00 1 cm from the nipple at the area of palpable concern demonstrates a hypoechoic oval circumscribed parallel mass without posterior features. This mass measures 1.8 × 1.6 × 0.6 cm. DBT of the left breast: 12:00 1 cm from the nipple at the palpable area of concern demonstrates a high density oval mass with associated coarse heterogeneous calcifications.

Author

All authors have contributed and approved the final version of the manuscript.

Patient

IRB approval was obtained for the publication of the study and accompanying images.

Conclusion

In summary, this case highlights the complexity of diagnosing fibroadenomas, particularly when atypical features emerge in younger women. The 28-year-old patient presented with an involuted fibroadenoma, a rare occurrence given her age and lack of significant causes for hormonal changes. This emphasizes the necessity for careful imaging interpretation and thorough clinical assessment to differentiate benign lesions from potential malignancies. While fibroadenomas generally carry a low risk of malignant transformation, ongoing monitoring remains essential for all patients with these lesions. Ultimately, a multidisciplinary approach involving imaging, clinical history, and pathology is crucial for effective management.

Discussion

Complex fibroadenomas usually occur in older patients, with a median age of 47 years, while simple fibroadenomas are more commonly seen in younger patients, with a median age of 29 years [ 1 ]. This case reports presents a rare case of an involuted fibroadenoma in a 28-year-old female without any relevant medical or surgical history which would result in hormonal fluctuation. Fibroadenomas are classified as fibroepithelial lesions, which include both the stromal and epithelial components of the breast. They are characterized by a well-circumscribed, often lobulated mass with a mixture of stromal and glandular tissue [ 4 ]. Subtypes of fibroadenoma includes the classic type, which is the most common and well-defined. Less common variants include the juvenile fibroadenoma, which is larger and more aggressive and the complex fibroadenoma, which may contain additional features such as epithelial calcifications, apocrine metaplasia, sclerosing adenosis, and cysts larger than 3 mm. The hyalinized fibroadenoma is more common in postmenopausal women due to decreased hormonal stimulation, leading to involution with hyalinization and calcification, or in premenopausal women with Cowden syndrome [ 1 ]. With increasing age, fibroadenomas usually shrink and show reduced cellularity. Their uncommon occurrence in older women supports the idea of natural regression, which may result from infarction, calcification, or hyalinization [ 5 ]. Imaging findings of fibroadenomas can vary. On ultrasound, they typically appear as well-defined, hypoechoic masses with possible areas of increased echogenicity due to fibrotic changes. On mammography, they often present as well-circumscribed masses that may become less prominent as they involute, and calcifications may be present [ 3 ]. Involuting fibroadenomas typically present with coarse (>3 mm), popcorn calcifications on mammography [ 6 ]. On ultrasound, involuting fibroadenomas can have irregular shape and margins due to the degeneration process [ 7 ]. On MRI, fibroadenomas typically present as well-defined, lobulated, or oval-shaped masses with smooth, distinct margins. On T1-weighted images, they have variable appearance and are usually isointense or mildly hypointense compared to the surrounding breast tissue, while on T2-weighted images, they often appear hyperintense. After the administration of contrast, fibroadenomas exhibit homogeneous or heterogenous enhancement with nonenhancing septa seen in approximately 50% of cases [ 3 ]. Rapid enhancement and washout kinetics are seen in myxoid fibroadenomas, which overlaps with findings commonly seen in malignant etiologies [ 3 ]. Diagnosing fibroadenomas with atypical features can be challenging due to their varied presentations and overlapping features with other breast lesions. Complex fibroadenomas, which may contain additional radiologic/histologic features such as cysts, calcifications, or stromal hyperplasia, can resemble more concerning entities, leading to potential misinterpretation on imaging studies [ 1 ]. On mammography and ultrasound, these lesions may appear as irregular or heterogeneous masses, complicating the differentiation from malignant tumors. In addition, no mammographic or sonographic features reliably differentiate complex fibroadenomas from simple fibroadenomas [ 1 ]. Clinical, sonographic, and mammographic appearances can overlap between the 2 types. Biopsy decisions for these lesions should be guided by BI-RADS criteria. The presence of atypical features can create uncertainty in biopsy results, sometimes necessitating further sampling or imaging. Clinicians must rely on a combination of imaging findings, clinical history, and pathology results, which can sometimes be inconclusive. This diagnostic complexity underscores the importance of a multidisciplinary approach to evaluate suspicious findings in the context of a patient's overall clinical picture. While earlier studies have indicated that patients with fibroadenomas have a higher risk of breast carcinoma compared to age-matched women in the general population, the actual occurrence of malignant transformation from fibroadenomas to cancer is quite rare. One study has found no associated increased risk of malignancy in patients with complex fibroadenomas in a sample of over 2100 patients [ 8 ]. Consequently, the standard approach for managing biopsy-proven fibroadenomas is generally conservative, involving regular observation through serial ultrasound and/or mammography to monitor for any growth. Only a small percentage of women with these lesions require surgical excision [ 1 ].

Introduction

Fibroadenomas are benign breast tumors that predominantly affect young women, typically between the ages of 15 and 35, though they can occur in women of any age [ 1 ]. These tumors are the most common type of breast mass in younger women and often present as firm, mobile, and painless palpable lumps [ 2 ]. The pathophysiology of fibroadenoma involves an overgrowth of both stromal and epithelial components of the breast tissue. Initially, these tumors exhibit rapid growth due to hormonal stimulation, primarily by estrogen. As women age or experience hormonal changes, such as during menopause, after an oophorectomy, or following chemotherapy, fibroadenomas may undergo involution. This process involves the tumor becoming less cellular, being replaced by fibrous tissue, and potentially decreasing in size or even resolving completely [ 3 ]. Accurate diagnosis often requires correlating imaging findings with clinical presentation, such as patient’s age, and biopsy is often necessary to confirm the nature of the mass if suspicious features are identified on imaging [ 4 ].

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

References (8)

SciLite annotations

organisms 4
noordeloos 2009062 noordeloos 2009062 noordeloos 2009062 noordeloos 2009062
chemicals 2
estrogen estrogen

Source provenance

openalex
last seen: 2026-05-11T06:25:09.493344+00:00
pubmed
last seen: 2026-10-08T21:53:12.177029+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0 · commercial use OK